Schizotypal personality disorder: a current review.
The study of schizotypal personality disorder (SPD) is important clinically, as it is understudied, challenging to treat, often under-recognized or misdiagnosed, and associated with significant functional impairment. SPD also represents an intermediate schizophrenia-spectrum phenotype, and therefore, can provide a better understanding of the genetics, pathogenesis, and treatment of related psychotic illnesses. In this review we discuss recent findings of SPD related to epidemiology and functional impairment, heritability and genetics, working memory and cognitive impairments, social-affective disturbances, and neurobiology. Additionally, we examine the challenges associated with treating patients with SPD, as well as clinical recommendations. Finally, we address future directions and areas in need of further exploration.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Daniel R
DR
Rosell
Shira E
SE
Futterman
Antonia
A
McMaster
Larry J
LJ
Siever
D003072:Cognition Disorders / Q000175:diagnosis; D006233:Persons with Disabilities / Q000523:psychology; D006801:Humans; D008570:Memory, Short-Term / Q000502:physiology; D009483:Neuropsychological Tests; D012307:Risk Factors; D012569:Schizotypal Personality Disorder / Q000175:diagnosis / Q000503:physiopathology; D012920:Social Behavior Disorders / Q000175:diagnosis